Getting Fancy With Fiber

You don't have to eat this to get the right fiber!

Fiber advice tends to arrive as a single number. Eat 30 grams a day and your gut, your weight, and apparently your GLP-1 medication will all fall into line. A recent review in the journal Advances in Nutrition makes the case that this flat recommendation misses most of what actually matters, and the details are worth walking through if you are on a GLP-1 medication or just trying to eat well during perimenopause.

Start with what fiber and GLP-1 medications have in common. Both work through the gut-brain axis, just by different routes. A GLP-1 drug binds directly to GLP-1 receptors and turns the signal on. Fiber does it indirectly. Certain fibers get fermented by gut bacteria into short-chain fatty acids, and those short-chain fatty acids bind to receptors on the cells lining your intestine, which then triggers your own body to release more GLP-1 naturally. Fiber is not just filler. It is nudging the same biological pathway your medication uses, just through your gut microbiome instead of an injection.

That does not mean fiber and medication are interchangeable. The review is clear that they are not. Semaglutide at the standard weekly dose produced close to 15 percent body weight reduction over 68 weeks in trial data. Fiber alone, even the more potent fermentable types, produced a fraction of that. Psyllium fiber reduced body weight by about 2 kilograms over five months in one trial. That is a real effect, and worth having in your routine, but it is not a substitute for medication when medication is what someone actually needs.

Where it gets more useful is the idea that not all fiber does the same job, and timing matters. Psyllium and glucomannan work mechanically. They absorb water, expand in the stomach, and increase satiety and stool bulk directly. That makes them well suited to the early dose-escalation phase of a GLP-1 medication, when nausea and constipation are most likely to show up and bowel regularity is the immediate concern. Inulin works differently. It gets fermented by gut bacteria into those short-chain fatty acids that stimulate your own GLP-1 production, which makes it a better fit for the maintenance phase, or for the period after someone tapers off medication and is trying to hang onto some of that appetite regulation on their own.

This is also where the review pushes back on the "just eat more fiber" version of this advice. One of the researchers put it plainly: a blanket recommendation like 30 grams of fiber a day is too simplistic. The right fiber, in the right amount, depends on what phase of treatment someone is in and what problem they are actually trying to solve. Loading up on a fermentable fiber like inulin during the early weeks of dose escalation, when the gut is already adjusting to a slower-moving stomach, can make bloating and gas worse rather than better. The type of fiber matters just as much as the amount.

None of this is a reason to skip fiber if you are on a GLP-1 medication or navigating perimenopause. It is a reason to be more specific about it than "eat more." If constipation is the problem, a mechanical fiber like psyllium, introduced gradually with enough water, is the more targeted choice. If you are further along in treatment or thinking about what happens after you taper off, a fermentable fiber like inulin is doing different, longer-term work. Either way, fiber is not window dressing next to your medication. Weight regain after stopping GLP-1 medications is common, averaging close to 7 percent of body weight within a year in the data reviewed, and the researchers frame consistent fiber intake as one of the more accessible tools for holding onto ground after the medication's job is done.

TL:DR on the Study

Link to the study: https://doi.org/10.1016/j.advnut.2026.100647

The basics: A narrative review examined how dietary fiber and GLP-1 receptor agonist medications interact, since both work through related gut-brain pathways.

Who was in the study: Researchers from Maastricht University and KU Leuven reviewed existing trial data on fiber types, GLP-1 medications, and their combined effects, rather than running a new clinical trial themselves.

What they did: They compared the mechanisms and outcomes of different fiber types against GLP-1 medication data, and evaluated whether fiber timing and type should change across different phases of treatment.

The results: GLP-1 medications produced far greater weight loss than fiber alone (around 15 percent body weight versus roughly 2 kilograms with psyllium over five months), but fibers like psyllium and inulin support different needs at different treatment stages, mechanical bulk-forming fiber during dose escalation and fermentable fiber during maintenance or tapering.

Why it matters: A single "eat more fiber" recommendation ignores that fiber type and timing affect both side effect management and how well someone holds onto results after stopping medication.

The catch: This is a review of existing research, not a new randomized trial, and the authors note that no study has directly tested fiber supplementation alongside GLP-1 therapy compared to GLP-1 therapy alone.How it works (probably): Fermentable fibers get broken down by gut bacteria into short-chain fatty acids, which bind receptors on intestinal cells and trigger the body's own GLP-1 release, echoing the same pathway the medication targets directly.